Distinct chemokine signaling regulates integrin ligand specificity to dictate tissue-specific lymphocyte homing

Developmental Cell

Volumn 30, Issue 1, 2014, Pages 61-70

  Sun, Hao ^a   Liu, Jie ^a   Zheng, YaJuan ^a   Pan, YouDong ^a   Zhang, Kun ^a   Chen, JianFeng ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4BETA7 INTEGRIN; CCL25 CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CXCR3; INTEGRIN; KINDLIN 3; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; TALIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL ADHESION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LIGAND BINDING; LYMPHOCYTE HOMING; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY;

ANIMALS; CELL ADHESION; CELL ADHESION MOLECULES; CELL MOVEMENT; CHEMOKINE CXCL10; CHEMOKINE CXCL11; CHEMOKINES, CC; FLOW CYTOMETRY; IMMUNOBLOTTING; INTEGRINS; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORGAN SPECIFICITY; PHOSPHORYLATION; PROTEIN BINDING; SIGNAL TRANSDUCTION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84904339016     PISSN: 15345807     EISSN: 18781551     Source Type: Journal    
DOI: 10.1016/j.devcel.2014.05.002     Document Type: Article

References (40)

1. Akbari H., Zadeh M.M. Leukocyte adhesion deficiency. Indian J. Pediatr. 2001, 68:77-79.
2. Berlin C., Bargatze R.F., Campbell J.J., von Andrian U.H., Szabo M.C., Hasslen S.R., Nelson R.D., Berg E.L., Erlandsen S.L., Butcher E.C. alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 1995, 80:413-422.
3. Berlin-Rufenach C., Otto F., Mathies M., Westermann J., Owen M.J., Hamann A., Hogg N. Lymphocyte migration in lymphocyte function-associated antigen (LFA)-1-deficient mice. J.Exp. Med. 1999, 189:1467-1478.
4. Borgland S.L., Bowen G.P., Wong N.C., Libermann T.A., Muruve D.A. Adenovirus vector-induced expression of the C-X-C chemokine IP-10 is mediated through capsid-dependent activation of NF-kappaB. J.Virol. 2000, 74:3941-3947.
5. Butcher E.C., Picker L.J. Lymphocyte homing and homeostasis. Science 1996, 272:60-66.
6. Campbell J.J., Hedrick J., Zlotnik A., Siani M.A., Thompson D.A., Butcher E.C. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 1998, 279:381-384.
7. Cording S., Wahl B., Kulkarni D., Chopra H., Pezoldt J., Buettner M., Dummer A., Hadis U., Heimesaat M., Bereswill S., et al. The intestinal micro-environment imprints stromal cells to promote efficient Treg induction in gut-draining lymph nodes. Mucosal Immunol. 2014, 7:359-368.
8. Cox D., Brennan M., Moran N. Integrins as therapeutic targets: lessons and opportunities. Nat. Rev. Drug Discov. 2010, 9:804-820.
9. D'Agata I.D., Paradis K., Chad Z., Bonny Y., Seidman E. Leucocyte adhesion deficiency presenting as a chronic ileocolitis. Gut 1996, 39:605-608.
10. De Smedt T., Butz E., Smith J., Maldonado-López R., Pajak B., Moser M., Maliszewski C. CD8alpha(-) and CD8alpha(+) subclasses of dendritic cells undergo phenotypic and functional maturation invitro and invivo. J.Leukoc. Biol. 2001, 69:951-958.
11. Ebisuno Y., Katagiri K., Katakai T., Ueda Y., Nemoto T., Inada H., Nabekura J., Okada T., Kannagi R., Tanaka T., et al. Rap1 controls lymphocyte adhesion cascade and interstitial migration within lymph nodes in RAPL-dependent and -independent manners. Blood 2010, 115:804-814.
12. Erle D.J., Briskin M.J., Butcher E.C., Garcia-Pardo A., Lazarovits A.I., Tidswell M. Expression and function of the MAdCAM-1 receptor, integrin alpha 4 beta 7, on human leukocytes. J.Immunol. 1994, 153:517-528.
13. Gawecka J.E., Young-Robbins S.S., Sulzmaier F.J., Caliva M.J., Heikkilä M.M., Matter M.L., Ramos J.W. RSK2 protein suppresses integrin activation and fibronectin matrix assembly and promotes cell migration. J.Biol. Chem. 2012, 287:43424-43437.
14. Gui G.P., Wells C.A., Yeomans P., Jordan S.E., Vinson G.P., Carpenter R. Integrin expression in breast cancer cytology: a novel predictor of axillary metastasis. Eur. J. Surg. Oncol. 1996, 22:254-258.
15. Hartmann T.N., Grabovsky V., Pasvolsky R., Shulman Z., Buss E.C., Spiegel A., Nagler A., Lapidot T., Thelen M., Alon R. A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells. J.Leukoc. Biol. 2008, 84:1130-1140.
16. Hirano T., Ishihara K., Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 2000, 19:2548-2556.
17. Hogg N., Patzak I., Willenbrock F. The insider's guide to leukocyte integrin signalling and function. Nat. Rev. Immunol. 2011, 11:416-426.
18. Humphries J.D., Byron A., Humphries M.J. Integrin ligands at aglance. J.Cell Sci. 2006, 119:3901-3903.
19. Johansson-Lindbom B., Agace W.W. Generation of gut-homing Tcells and their localization to the small intestinal mucosa. Immunol. Rev. 2007, 215:226-242.
20. Kamata T., Puzon W., Takada Y. Identification of putative ligand-binding sites of the integrin alpha 4 beta 1 (VLA-4, CD49d/CD29). Biochem. J. 1995, 305:945-951.
21. Kiema T., Lad Y., Jiang P., Oxley C.L., Baldassarre M., Wegener K.L., Campbell I.D., Ylänne J., Calderwood D.A. The molecular basis of filamin binding to integrins and competition with talin. Mol. Cell 2006, 21:337-347.
22. Kim M., Carman C.V., Yang W., Salas A., Springer T.A. The primacy of affinity over clustering in regulation of adhesiveness of the integrin alphaLbeta2. J.Cell Biol. 2004, 167:1241-1253.
23. Kinashi T. Intracellular signalling controlling integrin activation in lymphocytes. Nat. Rev. Immunol. 2005, 5:546-559.
24. Kunkel E.J., Butcher E.C. Chemokines and the tissue-specific migration of lymphocytes. Immunity 2002, 16:1-4.
25. LaFayette S.L., Collins C., Zaas A.K., Schell W.A., Betancourt-Quiroz M., Gunatilaka A.A., Perfect J.R., Cowen L.E. PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90. PLoS Pathog. 2010, 6:e1001069.
26. Lefort C.T., Ley K. Neutrophil arrest by LFA-1 activation. Front. Immunol. 2012, 3:157.
27. Lefort C.T., Rossaint J., Moser M., Petrich B.G., Zarbock A., Monkley S.J., Critchley D.R., Ginsberg M.H., Fässler R., Ley K. Distinct rolesfor talin-1 and kindlin-3 in LFA-1 extension and affinity regulation. Blood 2012, 119:4275-4282.
28. Legate K.R., Fässler R. Mechanisms that regulate adaptor binding to beta-integrin cytoplasmic tails. J.Cell Sci. 2009, 122:187-198.
29. Mora J.R., von Andrian U.H. T-cell homing specificity and plasticity: new concepts and future challenges. Trends Immunol. 2006, 27:235-243.
30. Moretti F.A., Moser M., Lyck R., Abadier M., Ruppert R., Engelhardt B., Fässler R. Kindlin-3 regulates integrin activation and adhesion reinforcement of effector Tcells. Proc. Natl. Acad. Sci. USA 2013, 110:17005-17010.
31. Mori N., Horie Y., Gerritsen M.E., Anderson D.C., Granger D.N. Anti-inflammatory drugs and endothelial cell adhesion molecule expression inmurine vascular beds. Gut 1999, 44:186-195.
32. Moser M., Nieswandt B., Ussar S., Pozgajova M., Fässler R. Kindlin-3 is essential for integrin activation and platelet aggregation. Nat. Med. 2008, 14:325-330.
33. Moser M., Legate K.R., Zent R., Fässler R. The tail of integrins, talin, and kindlins. Science 2009, 324:895-899.
34. Ratnakumar S., Kacherovsky N., Arms E., Young E.T. Snf1 controls the activity of adr1 through dephosphorylation of Ser230. Genetics 2009, 182:735-745.
35. Sakai T., Jove R., Fässler R., Mosher D.F. Role of the cytoplasmic tyrosines of beta 1A integrins in transformation by v-src. Proc. Natl. Acad. Sci. USA 2001, 98:3808-3813.
36. Santamaria Babi L.F., Moser R., Perez Soler M.T., Picker L.J., Blaser K., Hauser C. Migration of skin-homing Tcells across cytokine-activated human endothelial cell layers involves interaction of the cutaneous lymphocyte-associated antigen (CLA), the very late antigen-4 (VLA-4), and the lymphocyte function-associated antigen-1 (LFA-1). J.Immunol. 1995, 154:1543-1550.
37. Soler D., Chapman T., Yang L.L., Wyant T., Egan R., Fedyk E.R. The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7integrin therapeutic antibody in development for inflammatory bowel diseases. J.Pharmacol. Exp. Ther. 2009, 330:864-875.
38. Svensson L., Howarth K., McDowall A., Patzak I., Evans R., Ussar S., Moser M., Metin A., Fried M., Tomlinson I., Hogg N. Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation. Nat. Med. 2009, 15:306-312.
39. Takagi J., Petre B.M., Walz T., Springer T.A. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell 2002, 110. 599-11.
40. Yu B.Z., Zheng J., Yu A.M., Shi X.Y., Liu Y., Wu D.D., Fu W., Yang J. Effects of protein kinase C on M-phase promoting factor in early development of fertilized mouse eggs. Cell Biochem. Funct. 2004, 22:291-298.